Amy Moss Trombly - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Amy Moss Trombly has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Amy Moss Trombly is the Chief Executive Officer at Sonoma Pharmaceuticals, Inc. (SNOA). Trombly has reported 3 insider filings with the SEC since 2026. The most recent filing was in July 2026.
| Role | Chief Executive Officer |
|---|---|
| Notability | 40/100 |
Board memberships
- Sonoma Pharmaceuticals, Inc.
Reported roles
- Chief Executive Officer
Awards & honors
- Leading corporate strategy for Sonoma's dermatology portfolio
- Overseeing development and commercialization efforts for the company's products
- Guiding organizational growth and leadership during their recent SEC reporting period
Trading Pattern
InsiderAlpha's records for Amy Moss Trombly go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Amy Moss Trombly has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Executive Officer at Sonoma Pharmaceuticals, Inc. (SNOA) - 2 filings, 2026
Companies - Last 90 Days
- Sonoma Pharmaceuticals, Inc. (SNOA) - 1 filing, last 2026-07-10
Most Active Insiders Right Now
Amy Moss Trombly has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Apollo Principal Holdings B GP, LLC
- Apollo Principal Holdings B, L.P.
- ARCH Venture Partners XII, LLC
- ARCH Venture Partners XIII, LLC
- Audax Private Credit Business, LP
- Milton C. Ault III
- BAIN CAPITAL INVESTORS LLC
- Bain Capital Life Sciences Investors, LLC
Frequently Asked Questions
Who is Amy Moss Trombly?
Amy Moss Trombly is the Chief Executive Officer at Sonoma Pharmaceuticals, Inc. (SNOA). Trombly has reported 3 insider filings with the SEC since 2026. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Amy Moss Trombly submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Amy Moss Trombly's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Amy Moss Trombly profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.